Iron Deficiency

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2022-07-28
Clinical Trial Update: Iron Substitution With Ferric Carboxymaltose as Treatment Strategy for Heart Failure Patients With Preserved Ejection Fraction [Phase 4]
A Phase 4 trial evaluating ferric carboxymaltose for iron deficiency in heart failure with preserved ejection fraction has been withdrawn.